- Home
- ASND vs CR Comparison
ASND vs CR Comparison
Compare ASND & CR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- CR
- Stock Information
- Founded
- ASND 2006
- CR 1855
- Country
- ASND Denmark
- CR United States
- Employees
- ASND N/A
- CR N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- CR Metal Fabrications
- Sector
- ASND Health Care
- CR Industrials
- Exchange
- ASND Nasdaq
- CR Nasdaq
- Market Cap
- ASND 10.6B
- CR 11.1B
- IPO Year
- ASND 2015
- CR N/A
- Fundamental
- Price
- ASND $198.32
- CR $189.14
- Analyst Decision
- ASND Strong Buy
- CR Strong Buy
- Analyst Count
- ASND 16
- CR 4
- Target Price
- ASND $239.50
- CR $221.50
- AVG Volume (30 Days)
- ASND 549.0K
- CR 238.1K
- Earning Date
- ASND 08-07-2025
- CR 07-28-2025
- Dividend Yield
- ASND N/A
- CR 0.49%
- EPS Growth
- ASND N/A
- CR 44.57
- EPS
- ASND N/A
- CR 6.02
- Revenue
- ASND $576,332,355.00
- CR $2,227,200,000.00
- Revenue This Year
- ASND $79.35
- CR $10.22
- Revenue Next Year
- ASND $76.18
- CR $10.98
- P/E Ratio
- ASND N/A
- CR $36.67
- Revenue Growth
- ASND 54.50
- CR 18.63
- 52 Week Low
- ASND $111.09
- CR $127.04
- 52 Week High
- ASND $199.99
- CR $203.89
- Technical
- Relative Strength Index (RSI)
- ASND 69.11
- CR 45.07
- Support Level
- ASND $187.24
- CR $192.83
- Resistance Level
- ASND $197.67
- CR $199.88
- Average True Range (ATR)
- ASND 8.86
- CR 4.44
- MACD
- ASND 1.92
- CR -0.74
- Stochastic Oscillator
- ASND 95.73
- CR 7.17
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.